Latest Commercialization News

Renascor Resources' cost study estimates its hydrofluoric acid-free purification method can produce battery-grade graphite at about US$459 per tonne, positioning it as a competitive ex-China alternative to conventional HF-based processes.

Rimfire Pacific Mining has engaged UK-based Xcelsior Capital Advisors to support funding, government relations, and marketing for its NSW scandium projects, leveraging Xcelsior’s ties to the Wogen group and global critical minerals networks.

Archer Materials made significant strides in quantum chip fabrication and quantum neural network fraud detection, while progressing its Biochip beta prototype. A $7 million placement post-quarter strengthens its financial position to accelerate development and commercialisation.

Synertec’s Powerhouse platform has been selected by Amplitude Energy to optimise power at the Orbost Gas Processing Plant, marking a strategic step into large-scale industrial energy solutions.

Locksley Resources has demonstrated significant progress in antimony recovery through its collaboration with Rice University, successfully upgrading raw ore to high-purity antimony products and producing metallic antimony via electrodeposition.

Freehill Mining has signed a non-binding MOU with Austral Gold to fast-track copper and copper-gold project development in Chile, leveraging Austral’s operational expertise to boost Freehill’s strategic growth.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

Victory Metals advances its North Stanmore project by sending heavy rare earth concentrate to potential offtake partners and expanding its ore reserve through updated geological classification.

Element 25 is pushing ahead with its Butcherbird manganese mine expansion in Western Australia and developing a first-of-its-kind US high-purity manganese sulphate facility, backed by major OEM partnerships and a US$166 million DOE grant.

Dimerix will provide continued access to its investigational drug DMX-200 for eligible patients with focal segmental glomerular sclerosis after completing the pivotal ACTION3 Phase 3 trial, supporting ongoing treatment ahead of regulatory approval.

Finder Energy has secured regulatory approval for its Kuda Tasi and Jahal offshore development in Timor-Leste, significantly advancing the project towards a final investment decision and first oil by 2028.

American Tungsten & Antimony Ltd (ASX: AT4) has named Casper Adson as CEO to spearhead its metallurgical strategy, aiming to transform its US antimony and tungsten assets into defence-grade products and tap into US government funding.